Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Danaher Co. (NYSE:DHR). In a filing disclosed on February 27th, the Senator disclosed that they had sold between $15,001 and $50,000 in Danaher stock on February 13th.
Senator Markwayne Mullin also recently made the following trade(s):
- Purchased $15,001 – $50,000 in shares of Amazon.com (NASDAQ:AMZN) on 2/13/2025.
- Sold $15,001 – $50,000 in shares of Honeywell International (NASDAQ:HON) on 2/13/2025.
- Purchased $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 2/13/2025.
- Sold $15,001 – $50,000 in shares of Brick (TSE:BRK) on 2/13/2025.
- Sold $100,001 – $250,000 in shares of Vanguard Materials ETF (NYSEARCA:VAW) on 2/13/2025.
- Purchased $50,001 – $100,000 in shares of Microsoft (NASDAQ:MSFT) on 2/13/2025.
- Sold $15,001 – $50,000 in shares of Constellation Brands (NYSE:STZ) on 2/13/2025.
- Purchased $50,001 – $100,000 in shares of LPL Financial (NASDAQ:LPLA) on 2/13/2025.
- Purchased $15,001 – $50,000 in shares of TJX Companies (NYSE:TJX) on 2/13/2025.
- Sold $50,001 – $100,000 in shares of Advanced Micro Devices (NASDAQ:AMD) on 2/13/2025.
Danaher Stock Down 1.8 %
Shares of NYSE DHR opened at $205.69 on Friday. The stock has a market capitalization of $147.01 billion, a price-to-earnings ratio of 38.96, a P/E/G ratio of 2.66 and a beta of 0.83. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm’s 50-day moving average price is $225.00 and its 200-day moving average price is $245.50.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s payout ratio is 24.24%.
Insider Buying and Selling at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is owned by insiders.
Analyst Ratings Changes
DHR has been the topic of a number of analyst reports. Wells Fargo & Company cut their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Jefferies Financial Group cut their target price on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Finally, Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.
View Our Latest Analysis on DHR
Institutional Investors Weigh In On Danaher
Large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in Danaher by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after buying an additional 315,912 shares during the period. FMR LLC increased its holdings in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after acquiring an additional 3,217,631 shares during the period. Geode Capital Management LLC raised its position in shares of Danaher by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock worth $3,056,996,000 after acquiring an additional 315,446 shares in the last quarter. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter worth $2,130,740,000. Finally, Bank of New York Mellon Corp boosted its position in Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after purchasing an additional 441,012 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
About Senator Mullin
Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.